By PRNewswire
DUBLIN, Calif. — Effective Oct. 1, the Medi-Cal Fee-For-Service program is providing unrestricted $0 copay access to naloxone for patients.
As a result of the decision, beneficiaries can now obtain the drug in its nasal spray form from pharmacists across the state within 24 hours, establishing an unprecedented level of access and coverage.
The announcement builds on California’s steady commitment to improving statewide opioid safety.
“California continues to pave the way for educating patients, collaborating with physicians and improving community access to this potentially lifesaving medication,” Seamus Mulligan, chairman and CEO of Adapt Pharma, said. “The Medi-Cal Fee-For-Service program’s decision to provide restriction-free, no-cost access of Narcan nasal spray to its beneficiaries is a tangible and measurable achievement in the state’s broader initiative to combat this epidemic – and ultimately save the lives of Californians vulnerable to opioid-related overdose.”